{"id":"https://openalex.org/W4402014367","doi":"https://doi.org/10.18203/2319-2003.ijbcp20242417","title":"Cost analysis of drugs used in management of heart failure with reduced ejection fraction and marketed in India","display_name":"Cost analysis of drugs used in management of heart failure with reduced ejection fraction and marketed in India","publication_year":2024,"publication_date":"2024-08-28","ids":{"openalex":"https://openalex.org/W4402014367","doi":"https://doi.org/10.18203/2319-2003.ijbcp20242417"},"language":"en","primary_location":{"id":"doi:10.18203/2319-2003.ijbcp20242417","doi":"https://doi.org/10.18203/2319-2003.ijbcp20242417","is_oa":true,"landing_page_url":"http://dx.doi.org/10.18203/2319-2003.ijbcp20242417","pdf_url":"https://www.ijbcp.com/index.php/ijbcp/article/download/5635/3725","source":{"id":"https://openalex.org/S2764844374","display_name":"International Journal of Basic & Clinical Pharmacology","issn_l":"2279-0780","issn":["2279-0780","2319-2003"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4322697004","host_organization_name":"Medip Academy","host_organization_lineage":["https://openalex.org/P4322697004"],"host_organization_lineage_names":["Medip Academy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Basic & Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.ijbcp.com/index.php/ijbcp/article/download/5635/3725","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106836136","display_name":"Daya Tupe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802985673","display_name":"Cooper Hospital","ror":"https://ror.org/02ry07h90","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I2802985673"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Daya Tupe","raw_affiliation_strings":["Department of Pharmacology, HBTMC and Dr. R. N. Cooper Hospital, Mumbai, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, HBTMC and Dr. R. N. Cooper Hospital, Mumbai, Maharashtra, India","institution_ids":["https://openalex.org/I2802985673"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039709987","display_name":"Kiran A. Bhave","orcid":"https://orcid.org/0009-0006-1145-4341","observed_orcids":["https://orcid.org/0009-0006-1145-4341"]},"institutions":[{"id":"https://openalex.org/I2802985673","display_name":"Cooper Hospital","ror":"https://ror.org/02ry07h90","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I2802985673"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Kiran Bhave","raw_affiliation_strings":["Department of Pharmacology, HBTMC and Dr. R. N. Cooper Hospital, Mumbai, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, HBTMC and Dr. R. N. Cooper Hospital, Mumbai, Maharashtra, India","institution_ids":["https://openalex.org/I2802985673"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091594827","display_name":"Prasad R. Pandit","orcid":"https://orcid.org/0009-0005-0901-135X","observed_orcids":["https://orcid.org/0009-0005-0901-135X"]},"institutions":[{"id":"https://openalex.org/I2802985673","display_name":"Cooper Hospital","ror":"https://ror.org/02ry07h90","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I2802985673"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Prasad Pandit","raw_affiliation_strings":["Department of Pharmacology, HBTMC and Dr. R. N. Cooper Hospital, Mumbai, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, HBTMC and Dr. R. N. Cooper Hospital, Mumbai, Maharashtra, India","institution_ids":["https://openalex.org/I2802985673"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2802985673"],"apc_list":null,"apc_paid":null,"fwci":0.2738,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.55127507,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"13","issue":"5","first_page":"612","last_page":"618"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heart-failure-with-reduced-ejection-fraction","display_name":"heart failure with reduced ejection fraction","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-cost-analysis","display_name":"drug cost analysis","score":0.7160000205039978},{"id":"https://openalex.org/keywords/cost-ratio","display_name":"cost ratio","score":0.7070000171661377},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.7429999709129333},{"id":"https://openalex.org/keywords/spironolactone","display_name":"spironolactone","score":0.7689999938011169},{"id":"https://openalex.org/keywords/telmisartan","display_name":"telmisartan","score":1.0},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.5730000138282776},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6349999904632568},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.5559999942779541},{"id":"https://openalex.org/keywords/india","display_name":"India","score":0.5740000009536743}],"concepts":[{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.7679892182350159},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.6321825981140137},{"id":"https://openalex.org/C149629883","wikidata":"https://www.wikidata.org/wiki/Q660926","display_name":"Fraction (chemistry)","level":2,"score":0.6228897571563721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4592151641845703},{"id":"https://openalex.org/C2781374807","wikidata":"https://www.wikidata.org/wiki/Q6746704","display_name":"Management of heart failure","level":3,"score":0.439956933259964},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.38175469636917114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35426682233810425},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3342341184616089},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1959545612335205},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.10869249701499939}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.18203/2319-2003.ijbcp20242417","doi":"https://doi.org/10.18203/2319-2003.ijbcp20242417","is_oa":true,"landing_page_url":"http://dx.doi.org/10.18203/2319-2003.ijbcp20242417","pdf_url":"https://www.ijbcp.com/index.php/ijbcp/article/download/5635/3725","source":{"id":"https://openalex.org/S2764844374","display_name":"International Journal of Basic & Clinical Pharmacology","issn_l":"2279-0780","issn":["2279-0780","2319-2003"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4322697004","host_organization_name":"Medip Academy","host_organization_lineage":["https://openalex.org/P4322697004"],"host_organization_lineage_names":["Medip Academy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Basic & Clinical Pharmacology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.18203/2319-2003.ijbcp20242417","doi":"https://doi.org/10.18203/2319-2003.ijbcp20242417","is_oa":true,"landing_page_url":"http://dx.doi.org/10.18203/2319-2003.ijbcp20242417","pdf_url":"https://www.ijbcp.com/index.php/ijbcp/article/download/5635/3725","source":{"id":"https://openalex.org/S2764844374","display_name":"International Journal of Basic & Clinical Pharmacology","issn_l":"2279-0780","issn":["2279-0780","2319-2003"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4322697004","host_organization_name":"Medip Academy","host_organization_lineage":["https://openalex.org/P4322697004"],"host_organization_lineage_names":["Medip Academy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Basic & Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4402014367.pdf","grobid_xml":"https://content.openalex.org/works/W4402014367.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2018324826","https://openalex.org/W2600784710","https://openalex.org/W2602349340","https://openalex.org/W2805254239","https://openalex.org/W2944241246","https://openalex.org/W4210937888","https://openalex.org/W4291993757"],"related_works":["https://openalex.org/W4386775790","https://openalex.org/W7126200865","https://openalex.org/W3135379316","https://openalex.org/W4386271690","https://openalex.org/W3109855640","https://openalex.org/W7117132764","https://openalex.org/W2954233823","https://openalex.org/W4328031157","https://openalex.org/W4382450157","https://openalex.org/W4226191323"],"abstract_inverted_index":{"Background:":[0],"Heart":[1],"failure":[2],"is":[3,227],"characterised":[4],"by":[5,85],"significant":[6,194],"morbidity,":[7],"mortality,":[8],"poor":[9],"functional":[10],"capacity,":[11],"reduced":[12],"quality":[13],"of":[14,19,31,37,50,53,78,96,140,145,154,170,184,200,210,243],"life,":[15],"and":[16,70,109,117,172,186,216],"high":[17],"cost":[18,29,48,119,132,168,174,182,188,195],"lifelong":[20],"medications.":[21],"No":[22],"studies":[23],"have":[24],"been":[25],"performed":[26],"yet":[27],"on":[28],"analysis":[30],"oral":[32],"drugs":[33,55,157,203],"used":[34,206],"in":[35,59,67,73,81,89,197,207],"management":[36,156,209],"HFrEF":[38,155],"(Heart":[39],"Failure":[40],"with":[41],"Reduced":[42],"Ejection":[43],"Fraction).":[44],"So,":[45],"we":[46],"analysed":[47],"variations":[49],"different":[51,86,159,198],"brands":[52,153,199],"such":[54,244],"which":[56,68],"are":[57,205],"marketed":[58],"India.":[60],"Methods:":[61],"It":[62],"was":[63],"an":[64],"analytical":[65],"study":[66,192],"maximum":[69],"minimum":[71],"costs":[72],"rupees":[74],"per":[75],"10":[76],"tablets/capsules":[77],"each":[79,124],"drug":[80],"same":[82,202],"strength,":[83],"manufactured":[84],"pharmaceutical":[87],"companies":[88],"India,":[90],"were":[91,121,161],"obtained":[92],"from":[93,158],"\u201cCurrent":[94],"Index":[95],"Medical":[97],"Specialties\u201d":[98],"(CIMS)":[99],"January":[100],"to":[101,217,220,231,238],"April":[102,113],"2023,":[103],"Indian":[104],"Drug":[105,110],"Review":[106],"(IDR":[107],"2023)":[108],"Today":[111],"(January\u2013":[112],"2023":[114],"Cost":[115,127,137],"ratio":[116,169,183],"%":[118,126],"variation":[120,196],"calculated":[122],"for":[123,229],"drug.":[125],"variation=":[128],"Maximum":[129],"cost-":[130],"Minimum":[131,135],"\u00d7":[133],"100/":[134],"cost.":[136],"ratio=":[138],"Price":[139,144],"the":[141,146,201,208,224,240],"costliest":[142],"brand/":[143],"least":[147,233],"costly":[148,234],"brand.":[149],"Results:":[150],"Totally":[151],"652":[152],"classes":[160],"evaluated.":[162],"Telmisartan":[163],"80":[164],"mg":[165,179],"had":[166,180],"highest":[167],"44":[171],"4300%":[173],"variation,":[175],"while":[176],"Spironolactone":[177],"25":[178],"lowest":[181],"1.29":[185],"31.11%":[187],"variation.":[189],"Conclusions:":[190],"Our":[191],"showed":[193],"that":[204],"HFrEF.":[211],"To":[212],"lessen":[213],"economic":[214],"burden":[215],"improve":[218],"adherence":[219],"treatment,":[221],"also":[222],"considering":[223],"demographics,":[225],"it":[226],"desirable":[228],"doctors":[230],"prescribe":[232],"brands/":[235],"generic":[236],"drugs,":[237],"meet":[239],"health-care":[241],"needs":[242],"patients.":[245]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-08-30T00:00:00"}